The objective of this study is to confirm the role of c-fos in the regulation of 17-alpha hydroxylase (CYP17) and androgen production in granulosa cells from Polycystic ovary syndrome (PCOS) patients. The ovarian granulosa cells from the PCOS and non- PCOS patients during IVF/ICSI–ET are isolated and divided into two groups: The PCOS group and the control group,then they are cultured in vitro for 48 h. The following techniques are then used: The radioimmunoassay to determine the level of estradiol, progesterone,testosterone; The 2-NBDG as the fluorescence probe to detect the glucose uptake in granulosa cells; And Western Blot technology to analyze the cellular expressions of c-fos, and CYP17. The results show that compared with the control group,the testosterone secretion within ovarian granulosa cells from PCOS patients is increased (P<0.05), the progesterone level is significantly lower (P<0.05), the estradiol (P>0.05) does not change significantly, and the 2-NBDG uptake in granulosa cells is lower (P<0.05), indicating that the testosterone secretion within ovarian granulosa cells from PCOS patients is significantly increased, and the glucose metabolic disorders are present in granulosa cells from PCOS patients. The Western Blot shows that CYP17 (P<0.05) has a high expression in ovarian granulosa cells from PCOS patients compared with the control group patients, and the expression of c-fos is decreased (P<0.05), indicating that the c-fos may be one of the factors responsible for the CYP17 repression, and it may be one of the reasons for the increase in the testosterone production of granulose cells.
SANG Min
,
LI Jing
,
ZHANG Yuehui
,
WU Xiaoke
. The mechanism of c-fos gene regulation of 17-alpha hydroxylase (CYP17) expression and testosterone production in ovarian granulosa cells from polycystic ovary syndrome patients[J]. Science & Technology Review, 2015
, 33(22)
: 89
-92
.
DOI: 10.3981/j.issn.1000-7857.2015.22.015
[1] Manco M, Castagneto-Gissey L, Arrighi E, et al. Insulin dynamics in young women with polycystic ovary syndrome and normal glucose tolerance across categories of body mass index[J]. PLoS One, 2014, 9 (4): e92995.
[2] Sun J, Zhao J M, Ji R, et al. Effects of electroacupuncture of "Guanyuan" (CV 4)-"Zhongji" (CV 3) on ovarian P450 arom and P450c 17alpha expression and relevant sex hormone levels in rats with polycystic ovary syndrome[J]. Acupuncture Research, 2013, 38(6): 465-472.
[3] Jones M R, Chazenbalk G, Xu N, et al. Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility[J]. The Journal of Clinical Endocrinology and Metabolism, 2012, 97(9): E1750- E1757.
[4] Patel S S, Beshay V E, Escobar J C, et al. 17α-Hydroxylase (CYP17) expression and subsequent androstenedione production in the human ovary[J]. Reproductive Sciences, 2010, 17(11): 978-986.
[5] Ecklund L C, Usadi R S. Endocrine and reproductive effects of polycystic ovarian syndrome[J]. Obstetrics and Gynecology Clinics of North America, 2015, 42(1): 55-65.
[6] Hofland J, Steenbergen J, Hofland L J, et al. Protein kinase C-induced activin A switches adrenocortical steroidogenesis to aldosterone by suppressing CYP17A1 expression[J]. American Journal of Physiology Endocrinology and Metabolism, 2013, 305(6): E736-E744.
[7] Baptiste C G, Battista M C, Trottier A, et al. Insulin and hyperandrogenism in women with polycystic ovary syndrome[J]. The Journal of Steroid Biochemistry and Molecular Biology, 2010, 122(1-3): 42-52.
[8] Dewailly D, Hieronimus S, Mirakian P, et al. Polycystic ovary syndrome (PCOS)[J]. Annales D'endocrinologie, 2010, 71(1): 8-13.
[9] Abbott D H, Bacha F. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood[J]. Fertility and Sterility, 2013, 100(1): 2-11.
[10] Hoang Y D, McTavish K J, Chang R J, et al. Paracrine regulation of theca androgen production by granulosa cells in the ovary[J]. Fertility and Sterility, 2013, 100(2): 561-567.
